TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.
about
TUSC2 Immunogene Therapy Synergizes with Anti-PD-1 through Enhanced Proliferation and Infiltration of Natural Killer Cells in Syngeneic Kras-Mutant Mouse Lung Cancer Models.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@en
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@nl
type
label
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@en
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@nl
prefLabel
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@en
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@nl
P2093
P2860
P1476
TUSC2 Immunogene Therapy Syner ...... tant Mouse Lung Cancer Models.
@en
P2093
Boris Sepesi
David Rice
Heather Lin
Ismail M Meraz
Jack A Roth
Mourad Majidi
Veera Baladandayuthapani
P2860
P356
10.1158/2326-6066.CIR-17-0273
P577
2018-01-16T00:00:00Z